337 filings
Page 5 of 17
8-K
zxpgdmsxv8hccdwsah4
8 Jun 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021
8:01am
8-K
oglmtt dwv
11 May 21
Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021
8:01am
8-K
2fymyri5
4 May 21
Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update
8:04am
DEFA14A
o17c1dhl3 da8q4
22 Apr 21
Additional proxy soliciting materials
4:15pm
8-K
d9s36ocznwwiy7
7 Apr 21
Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021
8:01am
8-K
u8j in66lk70y
22 Mar 21
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients
9:39pm
8-K
22dtj1mr 3dz15vtm
9 Mar 21
Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021
8:02am
8-K
47bju 82t0itjns
25 Feb 21
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
8:03am
8-K
l5wfq5jznu4jw29fir2
10 Feb 21
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021
7:04am
8-K
qqzsfg c9
7 Jan 21
Pacira Reports Record Revenue for 2020 of $429.6 Million
7:33am
8-K
10ix2
9 Dec 20
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020
7:31am
8-K
3d0sxkeyi7
7 Dec 20
Departure of Directors or Certain Officers
8:01am
8-K
a04wk v8oqdwh91o
12 Nov 20
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020
7:50am
8-K
6t1mlxbgkxyhz qlx
29 Oct 20
Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update
8:04am
8-K
jmlhawui
7 Oct 20
Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020
8:04am
8-K
nrc8rzodtn67x2
9 Sep 20
Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million for August 2020
8:03am